Treatment with the HIV protease inhibitor nelfinavir triggers the unfolded protein response and may overcome proteasome inhibitor resistance of multiple myeloma in combination with bortezomib: a phase I trial (SAKK 65/08)

Author(s):
Driessen, C.; Kraus, M.; Joerger, M.; Rosing, H.; Bader, J.; Hitz, F.; Berset, C.; Xyrafas, A.; Hawle, H.; Berthod, G.; Overkleeft, H.S.; Sessa, C.; Huitema, A.; Pabst, T.; Moos, R. von; Hess, D.; Mey, U.J.
Published
2016
Publication type
Article / Letter to editor
Date issued
2016
Is part of
Haematologica (2016), Vol. 101, no. 3, p. 346-55
hdl
1887/44427